K-ras gene mutation site detection kit
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- 广州市宝创生物技术有限公司
- Publication Date
- 2020-02-25
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the fields of molecular biotechnology and gene detection, in particular to a K-ras gene mutation site detection kit. Background technique
[0002] K-ras is a small molecular G protein downstream of the EGFR signaling pathway. After mutation, its own GTPase activity is inhibited, so that the K-ras protein is always activated, and the signaling pathway is not regulated by the upstream EGFR signaling instructions. The mutation rate of K-ras gene in patients with colorectal cancer is about 40%, 70% occurs in the 12th codon, and 30% occurs in the 13th codon. K-ras gene mutation status is related to the curative effect of cetuximab, and cetuximab treatment is ineffective when K-ras gene mutation occurs. Drug regimen is very necessary. However, under normal circumstances, in actual clinical samples, the mutated gene is usually mixed with a large number of wild-type gene sequences, and because the sequences between the two are often ...